Table 2.
Classification and characteristics of histone deacetylases.
Class type | Class I | Class IIa | Class IIb | Class III | Class IV |
---|---|---|---|---|---|
Human HDAC |
HDAC-1, -2, -3, -8 |
HDAC-4, -5, -7, -9 |
HDAC-6, -10 |
SIRT1−7 |
HDAC11 |
Yeast homolog |
RPD3 |
HDA1 |
HDA1 |
SIR2 |
RPD3 |
Subcellular localization |
Nucleus |
Nucleus/cytoplasm |
Mostly cytoplasm |
Nucleus |
Nucleus/cytoplasm |
Tissue distribution |
Ubiquitous |
Brain, heart, skeletal muscle |
Liver, Kidney, spleen, pancreas |
Unknown |
Brain, heart, skeletal muscle, kidney |
Substrates (partial list) |
Histones, p53, E2F1, STAT1, STAT3, NF-κB, GATA1, YY1, MyoD, SHP, RelA, MEF2D, AR, GR |
Histones, GATA1, HP-1, SMAD7, PLAG1, PLAG2, GCMa |
Histones, tubulin, HSP90, SHP, SMAD7 |
Histones, tubulin, p53 |
Unknown |
Associated protein complexes (partial list) |
NuRD, SIN3, CoREST, NCoR, SMRT |
NCoR, SMRT |
|
PcG (PRC4) |
|
Binding partners (partial list) |
RB, BRCA1, DNMT1, DNMT3a, DNMT3b, MBD2−3, MeCP2, ATM |
HIF-1α, BCL-6, actinin, AR, ER, MEF2 |
RUNX2 |
|
|
Cofactor | Zn | Zn | Zn | NAD+ | Zn |
AR: Androgen receptor; ATM: Ataxia telangiectasia mutated; BCL-6: B-cell lymphoma 6; BRCA1: Breast cancer 1, early onset; CoREST: Corepressor for element-1-silencing transcription factor; DNMT1: DNA methyltransferase 1; ER: Estrogen receptor; GATA1: GATA binding protein 1; GCMa: Glial cells missing homolog α; GR: Glucocorticoid receptor; HDAC1: Histone deacetylase 1; HIF-1a: Hypoxia-inducible factor-1α; HP-1: Heterochromatin protein 1; HSP90: Heat shock protein 90; MBD2−3: Methyl-CpG binding domain 2−3; MeCP2: Methyl-CpG binding protein 2; MEF2: Myelin expression factor 2; MEF2D: Myocyte enhancer factor 2D; MyoD: Myogenic differentiation 1; NCoR: Nuclear receptor corepressor; NuRD: Nucleosome remodelling and histone deacetylase; PcG: Polycomb group; PLAG1−2: Pleiomorphic adenoma gene 1−2; RB: Retinoblastoma; RelA: v-rel reticuloendotheliosis viral oncogene homolog A; RPD3: Reduced potassium deficiency 3; RUNX2: Runt-related transcription factor 2; SHP: Small heterodimer partner; SIN3: SWI-independent 3; SIR2: Silencing information regulator 2; SMAD7: Mothers against decapentaplegic homolog 7; SMRT: Silencing mediator for retinoid and thyroid hormone receptors; STAT-1 and -3: Signal transducers and activators of transcription-1 and -3; YY1: YIN-YANG-1 transcription factor.